IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SRRK

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents0.440.430.320.290.150.140.180.080.090.090.100.070.110.150.100.130.310.100.210.18
Short-term Investments0.050.050.040.080.140.230.260.060.100.150.180.150.140.120.210.210.060.110.040.07
Total Current Assets0.510.520.390.390.320.390.450.150.200.250.290.230.260.290.330.360.390.230.270.26
Property, Plant & Equipment0.000.000.000.000.000.000.000.000.000.000.000.010.010.010.010.010.010.010.010.01
Total Non-current Assets*0.020.020.020.020.020.020.020.030.030.020.020.020.030.030.030.030.030.040.040.04
Total Assets0.520.540.400.410.340.410.470.180.230.270.310.250.280.310.360.390.420.270.300.30
Accounts Payable0.010.010.010.010.000.000.010.000.000.000.000.000.000.000.000.000.000.000.000.00
Short-term Debt----------------0.000.010.00--------0.000.010.010.00--
Total Current Liabilities0.070.060.060.060.050.040.050.040.030.040.030.030.020.030.040.030.040.030.060.06
Long-term Debt0.200.200.100.100.050.050.050.050.050.040.050.050.050.050.050.050.040.040.050.02
Total Non-current Liabilities*0.200.200.100.100.060.060.060.060.060.050.050.060.060.060.060.060.050.060.070.05
Total Liabilities0.270.260.160.170.110.100.110.100.090.080.090.080.080.090.100.100.090.090.130.11
Retained Earnings(1.52)(1.41)(1.30)(1.21)(1.11)(1.00)(0.92)(0.86)(0.79)(0.73)(0.68)(0.63)(0.59)(0.55)(0.51)(0.47)(0.43)(0.38)(0.38)(0.34)
Total Stockholder Equity0.250.280.250.240.230.310.370.080.130.180.230.170.200.230.260.290.330.170.170.19
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.000.000.000.000.00------------------0.000.000.0033.194.055.46
Research & Development58.2351.8146.8850.4962.4048.6850.3648.7242.3743.0934.9630.3426.8729.7429.6133.3932.0729.3729.0531.27
Selling, General & Admin50.6750.2045.0253.0649.7128.4118.9916.0617.1315.3313.0713.3412.2210.7710.8210.4711.0710.7610.3611.28
Total Operating Expenses108.90102.0291.90103.55112.1177.0969.3664.7859.5058.4248.0343.6739.0840.5140.4343.8643.1540.1339.4142.54
Operating Income(108.90)(102.02)(91.90)(103.55)(112.11)(77.09)(69.36)(64.78)(59.50)(58.42)(48.03)(43.67)(39.08)(40.51)(40.43)(43.86)(43.15)(6.93)(35.36)(37.08)
Net Income(109.90)(105.51)(90.96)(102.22)(110.03)(74.72)(66.45)(64.48)(58.51)(56.85)(46.13)(42.36)(37.92)(39.38)(39.26)(43.30)(44.00)(7.95)(35.91)(37.51)
Basic EPS(0.84)(0.83)(0.74)(0.90)(0.98)(0.67)(0.62)(0.66)(0.60)(0.59)(0.50)(0.53)(0.47)(0.49)(0.44)(0.55)(1.06)(0.21)(0.97)(1.02)
Diluted EPS(0.84)(0.83)(0.74)(0.90)(0.98)(0.67)(0.62)(0.66)(0.60)(0.59)(0.50)(0.53)(0.47)(0.49)(0.44)(0.55)(1.06)(0.21)(0.97)(1.02)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(70.31)(82.10)(75.50)(68.92)(76.94)(78.67)(49.51)(52.45)(49.20)(49.78)(37.35)(32.27)(32.55)(43.05)(28.91)(26.48)(34.74)(42.56)(32.45)(35.98)
Capital Expenditures0.000.070.030.080.220.270.020.030.020.020.000.000.040.030.120.030.480.440.541.41
Free Cash Flow*(70.31)(82.17)(75.53)(69.01)(77.16)(78.95)(49.53)(52.49)(49.22)(49.81)(37.35)(32.27)(32.59)(43.08)(29.02)(26.51)(35.22)(43.01)(33.00)(37.39)
Investing Cash Flow(5.50)(5.33)38.9759.7085.4734.55(195.37)35.3150.6233.38(25.13)(8.47)(15.24)89.980.08(145.72)44.52(70.58)29.463.28
Financing Cash Flow83.12193.7973.29144.476.474.17346.370.17(0.03)6.5396.530.284.691.08(0.97)(0.45)195.770.4839.701.91
← Scroll for more columns →

* Derived from reported values